A Multi-Level Evaluation of California's New Medicaid Coverage for the Diabetes Prevention Program
A Multi-Level Evaluation of California's New Medicaid Coverage for the Diabetes Prevention Program
批准号:
10876512
负责人:
OBIDIUGWU KENRIK, DURU
金额:
$14.28万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-07-27 至 2025-06-30
关键词:
AdultAffectAmericanAmputationAwarenessBlindnessBlood PressureBody WeightBody Weight decreasedCaliforniaCardiovascular DiseasesCenters for Disease Control and Prevention (U.S.)ClinicalCommunitiesContractsCost AnalysisCost SavingsDataDiabetes MellitusDiabetes preventionEconomic BurdenEffectivenessEligibility DeterminationEnrollmentEvaluationEvaluation ResearchFundingFutureGoalsHealthHealth InsuranceHealth ServicesHealth Services ResearchHealth systemInsurance CoverageInterviewKidney FailureLawsLife StyleLos AngelesLow incomeLower ExtremityMedicaidMedicaid eligibilityMedicalMedical Care CostsMiddle Class PopulationsMinorityNatural experimentNon-Insulin-Dependent Diabetes MellitusOutcomeOutcomes ResearchParticipantPatientsPersonsPhasePoliciesPolicy AnalysisPolicy MakerPopulationPositioning AttributePrediabetes syndromeProcessProductivityProgram EvaluationQualitative MethodsResearchResearch PersonnelStatutes and LawsStructureTarget PopulationsTechniquesUnited StatesUniversitiesadvanced analyticsbeneficiaryclinical outcome measurescohortcostdiabetes prevention programeffectiveness evaluationeligible participantexperiencehealth planimplementation barriersinsightmultidisciplinaryparticipant retentionpatient engagementpatient populationpolicy implicationpreventprimary outcomeprogramsrecruitsecondary outcomesuccessuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
The Diabetes Prevention Program (DPP) helps patients with prediabetes initiate lifestyle changes and delay or
prevent T2DM. However, the DPP has been most successful in middle-class populations. The Centers for
Disease Control and Prevention (CDC)-supported National Diabetes Prevention Program achieved widespread
implementation but had limited reach and effectiveness in low-income communities. In a major step forward,
California has mandated in Senate Bill 97 that as of January 1, 2019, all eligible Medicaid (e.g., Medi-Cal)
beneficiaries who want to enroll in the DPP must be provided this opportunity. The outcomes of SB 97 will
have major implications on diabetes prevention for Medicaid beneficiaries not only in California but also across
the US. We are proposing an evaluation of SB 97 using data from Kaiser Permanente Northern California
(KPNC) and the University of California, Los Angeles (UCLA). Using advanced analytic approaches, we will
evaluate the effects of this natural experiment on clinical outcomes. We will also collect important contextual
primary data from the 43 CDC-recognized or pending DPP suppliers in California, and from both DPP lifestyle
coaches and DPP participants.
Our Specific Aims are as follows: 1) To determine the effectiveness of SB 97 and mandated Medi-Cal DPP
coverage on change in body weight (primary outcome), systolic blood pressure (SBP), uptake of the DPP in-
person or online, and projected future cost savings (all secondary outcomes) among Medi-Cal beneficiaries
with prediabetes at KPNC and UCLA, versus a comparison cohort of patients with insurance coverage from the
California Health Insurance Exchange (HIE). 2) To characterize perspectives from leaders of CDC-recognized
DPP suppliers including decisions about providing DPP to Medi-Cal beneficiaries, such as their processes of
identifying the target population, raising awareness of and promoting the DPP, and recruiting and enrolling
eligible participants. 3) To characterize perspectives of Medi-Cal DPP participants and DPP lifestyle coaches
on facilitators and barriers to participant retention and engagement. Our team includes a collaborative group of
health services researchers, a statistician, and a health economist with experience in program evaluation and
outcomes research, who have a longstanding working relationship. If funded, we are well positioned and ready
to initiate the proposed policy evaluation in the post-enactment period.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
UCLA LIFT-UP (Leveraging Institutional support For Talented, Underrepresented Physicians and/or Scientists)
-
批准号:10451203
-
项目类别:
-
资助金额:$42.46万
-
财政年份:2022
-
负责人:OBIDIUGWU KENRIK, DURU
-
依托单位:
Evaluating Real-world Diabetes Prevention Programs in a Multi-campus University System and a Three-state Regional Health Network
-
批准号:10662416
-
项目类别:
-
资助金额:$57.0万
-
财政年份:2022
-
负责人:OBIDIUGWU KENRIK, DURU
-
依托单位:
UCLA LIFT-UP (Leveraging Institutional support For Talented, Underrepresented Physicians and/or Scientists)
-
批准号:10666450
-
项目类别:
-
资助金额:$71.52万
-
财政年份:2022
-
负责人:OBIDIUGWU KENRIK, DURU
-
依托单位:
Evaluating Real-world Diabetes Prevention Programs in a Multi-campus University System and a Three-state Regional Health Network
-
批准号:10554970
-
项目类别:
-
资助金额:$57.0万
-
财政年份:2022
-
负责人:OBIDIUGWU KENRIK, DURU
-
依托单位:
Cultivating Interest in Research Careers (CIRC)
-
批准号:10361122
-
项目类别:
-
资助金额:$12.85万
-
财政年份:2021
-
负责人:OBIDIUGWU KENRIK, DURU
-
依托单位:
A Shared Decision Making Intervention for Diabetes Prevention in Women with a History of Gestational Diabetes Mellitus.
-
批准号:10352442
-
项目类别:
-
资助金额:$57.53万
-
财政年份:2021
-
负责人:OBIDIUGWU KENRIK, DURU
-
依托单位:
The Impact of Reflective Motivation on the Effect of a Shared Decision Making Intervention for Diabetes Prevention
-
批准号:10826790
-
项目类别:
-
资助金额:$19.3万
-
财政年份:2021
-
负责人:OBIDIUGWU KENRIK, DURU
-
依托单位:
Cultivating Interest in Research Careers (CIRC)
-
批准号:10538649
-
项目类别:
-
资助金额:$12.85万
-
财政年份:2021
-
负责人:OBIDIUGWU KENRIK, DURU
-
依托单位:
A Shared Decision Making Intervention for Diabetes Prevention in Women with a History of Gestational Diabetes Mellitus.
-
批准号:10521308
-
项目类别:
-
资助金额:$56.4万
-
财政年份:2021
-
负责人:OBIDIUGWU KENRIK, DURU
-
依托单位:
UCLA-led Central Coordinating Center (CCC) for the Natural Experiment Research Network
-
批准号:10223862
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2020
-
负责人:OBIDIUGWU KENRIK, DURU
-
依托单位:
A Pragmatic Nationwide RCT of Coordinated Medical, Behavioral, and Social Services to Improve Care and Utilization among High-Cost, High-Need Insured Patients with Diabetes
-
批准号:10625400
-
项目类别:
-
资助金额:$45.75万
-
财政年份:2020
-
负责人:OBIDIUGWU KENRIK, DURU
-
依托单位:
A Multi-Level Evaluation of California's New Medicaid Coverage for the Diabetes Prevention Program
-
批准号:10440462
-
项目类别:
-
资助金额:$57.73万
-
财政年份:2020
-
负责人:OBIDIUGWU KENRIK, DURU
-
依托单位:
A Multi-Level Evaluation of California's New Medicaid Coverage for the Diabetes Prevention Program
-
批准号:10224188
-
项目类别:
-
资助金额:$58.73万
-
财政年份:2020
-
负责人:OBIDIUGWU KENRIK, DURU
-
依托单位:
UCLA-led Central Coordinating Center (CCC) for the Natural Experiment Research Network
-
批准号:10427107
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2020
-
负责人:OBIDIUGWU KENRIK, DURU
-
依托单位:
A Multi-Level Evaluation of California's New Medicaid Coverage for the Diabetes Prevention Program
-
批准号:10641811
-
项目类别:
-
资助金额:$56.94万
-
财政年份:2020
-
负责人:OBIDIUGWU KENRIK, DURU
-
依托单位:
UCLA-led Central Coordinating Center (CCC) for the Natural Experiment Research Network
-
批准号:10093777
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2020
-
负责人:OBIDIUGWU KENRIK, DURU
-
依托单位:
A Pragmatic Nationwide RCT of Coordinated Medical, Behavioral, and Social Services to Improve Care and Utilization among High-Cost, High-Need Insured Patients with Diabetes
-
批准号:10427105
-
项目类别:
-
资助金额:$45.75万
-
财政年份:2020
-
负责人:OBIDIUGWU KENRIK, DURU
-
依托单位:
UCLA-led Central Coordinating Center (CCC) for the Natural Experiment Research Network
-
批准号:10625399
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2020
-
负责人:OBIDIUGWU KENRIK, DURU
-
依托单位:
A Pragmatic Nationwide RCT of Coordinated Medical, Behavioral, and Social Services to Improve Care and Utilization among High-Cost, High-Need Insured Patients with Diabetes
-
批准号:10223879
-
项目类别:
-
资助金额:$45.75万
-
财政年份:2020
-
负责人:OBIDIUGWU KENRIK, DURU
-
依托单位:
A Pragmatic Nationwide RCT of Coordinated Medical, Behavioral, and Social Services to Improve Care and Utilization among High-Cost, High-Need Insured Patients with Diabetes
-
批准号:10093555
-
项目类别:
-
资助金额:$45.0万
-
财政年份:2020
-
负责人:OBIDIUGWU KENRIK, DURU
-
依托单位:
海外基金